Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters

Background: There is paucity of literature on the impact of teriparatide on hip geometry and bone microarchitecture globally and none from the Indian subcontinent. This study examined the outcome of teriparatide therapy on vertebral fractures, bone mineral density (BMD), hip structural analysis (HSA...

Full description

Bibliographic Details
Main Authors: Nandipati Venkata Sandeep, Aneez Joseph, Kripa Elizabeth Cherian, Nitin Kapoor, Thomas V Paul
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Therapeutic Advances in Endocrinology and Metabolism
Online Access:https://doi.org/10.1177/20420188221112903
_version_ 1811221805572030464
author Nandipati Venkata Sandeep
Aneez Joseph
Kripa Elizabeth Cherian
Nitin Kapoor
Thomas V Paul
author_facet Nandipati Venkata Sandeep
Aneez Joseph
Kripa Elizabeth Cherian
Nitin Kapoor
Thomas V Paul
author_sort Nandipati Venkata Sandeep
collection DOAJ
description Background: There is paucity of literature on the impact of teriparatide on hip geometry and bone microarchitecture globally and none from the Indian subcontinent. This study examined the outcome of teriparatide therapy on vertebral fractures, bone mineral density (BMD), hip structural analysis (HSA), and trabecular bone score (TBS) in Indian postmenopausal women with severe osteoporosis. Methodology: Ambulatory postmenopausal women above the age of 50 years with either severe osteoporosis or vertebral fractures, or both, were recruited. All patients received cholecalciferol (2000 IU/day), calcium carbonate (elemental calcium 1 g/day), and teriparatide (20 mcg subcutaneously/day) for 24 months. Baseline bone biochemistry, BMD, TBS, and HSA were assessed and repeated after 24 months of therapy. Incident vertebral and nonvertebral fractures were also studied. Results: A total of 51 postmenopausal women with mean (SD) age of 65.7(8.6) years, and mean (SD) body mass index of 22.7 (3.5) kg/m 2 were recruited in this study. Vertebral fractures were present in 74.5% (38/51) at baseline. Following teriparatide therapy, significant improvement was observed in the BMD (g/cm 2 ) at both the lumbar spine (0.706–0.758: p  < 0.001) and femoral neck (0.551–0.579: p  = 0.047) as well as the TBS (1.160–1.271: p  < 0.001). Most indices of proximal hip geometry also showed significant improvement following teriparatide therapy at 24 months. Incident vertebral fractures were noted in only 7.8% (4/51) of participants, while 92% (47/51) of participants did not develop any new vertebral fractures on follow-up. Conclusion: In South Indian postmenopausal women with either severe osteoporosis or vertebral fractures, or both, teriparatide was effective in improving the bone mineral parameters and bone quality.
first_indexed 2024-04-12T08:05:36Z
format Article
id doaj.art-483ad40ca3284a168fea299255903944
institution Directory Open Access Journal
issn 2042-0196
language English
last_indexed 2024-04-12T08:05:36Z
publishDate 2022-07-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Endocrinology and Metabolism
spelling doaj.art-483ad40ca3284a168fea2992559039442022-12-22T03:41:10ZengSAGE PublishingTherapeutic Advances in Endocrinology and Metabolism2042-01962022-07-011310.1177/20420188221112903Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parametersNandipati Venkata SandeepAneez JosephKripa Elizabeth CherianNitin KapoorThomas V PaulBackground: There is paucity of literature on the impact of teriparatide on hip geometry and bone microarchitecture globally and none from the Indian subcontinent. This study examined the outcome of teriparatide therapy on vertebral fractures, bone mineral density (BMD), hip structural analysis (HSA), and trabecular bone score (TBS) in Indian postmenopausal women with severe osteoporosis. Methodology: Ambulatory postmenopausal women above the age of 50 years with either severe osteoporosis or vertebral fractures, or both, were recruited. All patients received cholecalciferol (2000 IU/day), calcium carbonate (elemental calcium 1 g/day), and teriparatide (20 mcg subcutaneously/day) for 24 months. Baseline bone biochemistry, BMD, TBS, and HSA were assessed and repeated after 24 months of therapy. Incident vertebral and nonvertebral fractures were also studied. Results: A total of 51 postmenopausal women with mean (SD) age of 65.7(8.6) years, and mean (SD) body mass index of 22.7 (3.5) kg/m 2 were recruited in this study. Vertebral fractures were present in 74.5% (38/51) at baseline. Following teriparatide therapy, significant improvement was observed in the BMD (g/cm 2 ) at both the lumbar spine (0.706–0.758: p  < 0.001) and femoral neck (0.551–0.579: p  = 0.047) as well as the TBS (1.160–1.271: p  < 0.001). Most indices of proximal hip geometry also showed significant improvement following teriparatide therapy at 24 months. Incident vertebral fractures were noted in only 7.8% (4/51) of participants, while 92% (47/51) of participants did not develop any new vertebral fractures on follow-up. Conclusion: In South Indian postmenopausal women with either severe osteoporosis or vertebral fractures, or both, teriparatide was effective in improving the bone mineral parameters and bone quality.https://doi.org/10.1177/20420188221112903
spellingShingle Nandipati Venkata Sandeep
Aneez Joseph
Kripa Elizabeth Cherian
Nitin Kapoor
Thomas V Paul
Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
Therapeutic Advances in Endocrinology and Metabolism
title Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
title_full Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
title_fullStr Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
title_full_unstemmed Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
title_short Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters
title_sort impact of teriparatide therapy in indian postmenopausal women with osteoporosis with regard to dxa derived parameters
url https://doi.org/10.1177/20420188221112903
work_keys_str_mv AT nandipativenkatasandeep impactofteriparatidetherapyinindianpostmenopausalwomenwithosteoporosiswithregardtodxaderivedparameters
AT aneezjoseph impactofteriparatidetherapyinindianpostmenopausalwomenwithosteoporosiswithregardtodxaderivedparameters
AT kripaelizabethcherian impactofteriparatidetherapyinindianpostmenopausalwomenwithosteoporosiswithregardtodxaderivedparameters
AT nitinkapoor impactofteriparatidetherapyinindianpostmenopausalwomenwithosteoporosiswithregardtodxaderivedparameters
AT thomasvpaul impactofteriparatidetherapyinindianpostmenopausalwomenwithosteoporosiswithregardtodxaderivedparameters